Boardroom Alpha
Boardroom Alpha
KBR · Current Report (Form 8-K) · Filed May 18, 2026

Kbr Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 18, 2026
Period
May 14, 2026
Ticker
KBR
Accession
0001357615-26-000151
Boardroom Alpha · Filing insights

All director nominees were elected for 1-year terms. This outcome signals governance continuity at the board level.

About Kbr Inc
Market cap
$4.5B
1Y TSR
−33.6%
3Y TSR
−18.2%
Board grade
C-
Sector
Industrials
CEO
Stuart Bradie
Last annual meeting: May 14, 2026 · View full Kbr Inc profile →
kbr-20260514

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 14, 2026
 
 
KBR Logo.jpg
KBR, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3314620-4536774
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
601 Jefferson Street
Suite 3400
Houston,Texas77002
(Address of principal executive offices)
Registrant's telephone number including area code: (713) 753-2000
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which listed
Common Stock, $0.001 par valueKBRNew York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




ITEM 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders of KBR, Inc. (the “Company”), the Company’s stockholders voted on three matters. As of the record date, March 17, 2026, there were 126,789,441 shares of common stock outstanding and entitled to vote at the Annual Meeting of Stockholders. On the meeting date, holders of 115,781,483 shares were present in person or by proxy.

The proposals submitted to the stockholders of the Company at the Annual Meeting of Stockholders and the final voting results for each are set forth below. The proposals are described in detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on March 30, 2026.

ProposalForAgainstAbstentionsBroker non-votes
1. Election of Directors:
Stuart J. B. Bradie107,764,556702,46849,0617,265,398
Joseph Dominguez108,395,19365,75955,1337,265,398
Lynn A. Dugle100,068,8518,393,17054,0647,265,398
Nchacha E. Etta108,392,37369,15154,5617,265,398
Sir John A. Manzoni KCB104,950,5213,511,53454,0307,265,398
Lt. General Wendy M. Masiello, USAF (Ret.)108,412,65850,20053,2277,265,398
Jack B. Moore106,589,3211,872,03854,7267,265,398
Ann D. Pickard108,095,350366,44954,2867,265,398
Carlos A. Sabater107,195,580977,380343,1257,265,398
Huibert H. Vigeveno107,957,662503,61554,8087,265,398
Lewis F. Von Thaer107,216,3201,246,37153,3947,265,398

Each of the director nominees was elected for a one-year term expiring at the 2027 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier resignation or removal.

ProposalForAgainstAbstentionsBroker non-votes
2. Advisory vote to approve the compensation of our Named Executive Officers as disclosed in the proxy statement.104,759,0633,598,554158,4687,265,398

The advisory vote was in favor of approval of our executive compensation.

ProposalForAgainstAbstentionsBroker non-votes
3. Ratification of KPMG LLP as independent registered public accounting firm for the Company for the fiscal year ending January 1, 2027.112,072,3193,664,14345,021N/A

The selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending January 1, 2027, was ratified.




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
KBR, INC.
May 18, 2026/s/ Sonia Galindo
Sonia Galindo
Executive Vice President, General Counsel & Corporate Secretary


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Kbr Inc (KBR)

Reference

Frequently asked questions

When did Kbr Inc file this 8-K?
Kbr Inc (KBR) filed this Current Report (Form 8-K) with the SEC on May 18, 2026. The accession number assigned by EDGAR is 0001357615-26-000151.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
All director nominees were elected for 1-year terms. This outcome signals governance continuity at the board level. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Kbr Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Kbr Inc has filed under CIK 1357615, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer